ArticleAmerican journal of cancer research2019

Inhibition of cisplatin-resistant head and neck squamous cell carcinoma by combination of Afatinib with PD0325901, a MEK inhibitor.

Xiaofeng Lin et al.PubMed ↗Full text ↗

No numbers read from the abstract.